Clinical Trial Results:
A Phase 3, Randomized, Double-Blind Study Of Ceftobiprole Medocaril
Versus Vancomycin With Ceftazidime in The Treatment Of Complicated Skin
And Skin Structure Infections
Summary
|
|
EudraCT number |
2005-002301-23 |
Trial protocol |
HU LV LT EE CZ |
Global completion date |
13 Oct 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
09 Sep 2017
|
First version publication date |
09 Sep 2017
|
Other versions |
|
Summary report(s) |
BAP00414 (2005-002301-23)_CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.